NMC

NEA Management Company Portfolio holdings

AUM $1.33B
1-Year Return 85.82%
This Quarter Return
+49.26%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$1.93B
AUM Growth
+$421M
Cap. Flow
-$74.5M
Cap. Flow %
-3.87%
Top 10 Hldgs %
81.87%
Holding
41
New
4
Increased
–
Reduced
3
Closed
2

Top Buys

1
AKAO
Achaogen, Inc.
AKAO
$17.9M
2
CASC
Cascadian Therapeutics, Inc.
CASC
$10.1M
3
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
$9.95M
4
AKTX
Akari Therapeutics
AKTX
$6.1M

Top Sells

1
OPWR
OPOWER INC COM STK (DE)
OPWR
$61.3M
2
GRPN icon
Groupon
GRPN
$36M
3
OREX
Orexigen Therapeutics, Inc.
OREX
$14.4M
4
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
$817K

Sector Composition

1 Healthcare 77.16%
2 Technology 7.27%
3 Communication Services 5.59%
4 Consumer Discretionary 1.98%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AUPH icon
26
Aurinia Pharmaceuticals
AUPH
$1.65B
$7.06M 0.37%
2,546,843
– –
AKTX
27
Akari Therapeutics
AKTX
$23.5M
$6.1M 0.32%
+22,608
New +$6.1M
DZSI
28
DELISTED
DZS Inc. Common Stock
DZSI
$5.69M 0.3%
956,258
– –
ARQL
29
DELISTED
Arqule Inc
ARQL
$4.79M 0.25%
2,520,316
– –
VIRX
30
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$4.28M 0.22%
37,094
– –
ORKA
31
Oruka Therapeutics, Inc. Common Stock
ORKA
$562M
$4.24M 0.22%
6,760
– –
CSBR icon
32
Champions Oncology
CSBR
$94.7M
$3.36M 0.17%
1,562,500
– –
ZSAN
33
DELISTED
Zosano Pharma Corporation
ZSAN
$2.74M 0.14%
3,084
– –
ROKA
34
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
$1.84M 0.1%
322,043
– –
OREX
35
DELISTED
Orexigen Therapeutics, Inc.
OREX
$1.6M 0.08%
37,090
-333,810
-90% -$14.4M
AVTX icon
36
Avalo Therapeutics
AVTX
$135M
$1.31M 0.07%
207
– –
AGRX
37
DELISTED
Agile Therapeutics, Inc
AGRX
$1.02M 0.05%
67
– –
GYRE icon
38
Gyre Therapeutics
GYRE
$688M
$992K 0.05%
5,799
– –
PRTK
39
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$921K 0.05%
66,245
-58,759
-47% -$817K
OPWR
40
DELISTED
OPOWER INC COM STK (DE)
OPWR
– –
-8,997,290
Closed -$61.3M
1
2